Email: cspc@cspc.cn

Contact Us
EN

News

News

Home > Media > News > levidipine Injectable Emulsion Obtains Clinical Approval

levidipine Injectable Emulsion Obtains Clinical Approval

January 09, 2023

202305.png

202306.png

Previous: Octreotide Long-Acting Injection Obtains Clinical Trial Approval

Next: Meloxicam Nanocrystal Injection Obtains Clinical Trial Approval

Contact Us

Phone:

+86 311 8703 7015

Email:

cspc@cspc.cn

Products

Science

About Us

Legal terms Privacy protection
Copyright © CSPC PHARMACEUTICAL GROUP LIMITED All Rights Reserved | 冀ICP备05003393号

Wechat